Last update 21 Nov 2024

Retroviral ADA-transduced CD34+ cells(University of California, Los Angeles)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms-
Target
CD34
Mechanism
CD34 antagonists(Hematopoietic progenitor cell antigen CD34 antagonists)
Therapeutic Areas
Immune System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Adenosine deaminase deficiency
Inactive Indication-
Originator Organization
University of California, Los AngelesUniversity of California, Los Angeles
Active Organization
University of California, Los AngelesUniversity of California, Los Angeles
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Retroviral ADA-transduced CD34+ cells(University of California, Los Angeles)
NCT05432310 / RecruitingPhase 1/2IIT
Efficacy and Safety of Cryopreserved Autologous Mobilized Peripheral Blood CD34+ Hematopoietic Stem and Progenitor Cells Transduced Ex Vivo With the EFS-ADA Lentiviral Vector in Patients With Severe Combined Immune Deficiency Due To Adenosine Deaminase Deficiency
100 Clinical Results associated with Retroviral ADA-transduced CD34+ cells(University of California, Los Angeles)
Login to view more data
100 Translational Medicine associated with Retroviral ADA-transduced CD34+ cells(University of California, Los Angeles)
Login to view more data
100 Patents (Medical) associated with Retroviral ADA-transduced CD34+ cells(University of California, Los Angeles)
Login to view more data
100 Deals associated with Retroviral ADA-transduced CD34+ cells(University of California, Los Angeles)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenosine deaminase deficiencyPhase 2-
University of California, Los AngelesUniversity of California, Los Angeles
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free